Volume 62, Issue 6, Pages (December 2002)

Slides:

Advertisements

Similar presentations

LDL cholesterol in CKD—to treat or not to treat?

Advertisements

Associations Between Low Serum Testosterone and All-Cause Mortality and Infection- Related Hospitalization in Male Hemodialysis Patients: A Prospective.

Beta blockers in the management of chronic kidney disease

Volume 70, Issue 3, Pages (August 2006)

FGF-23 in patients with end-stage renal disease on hemodialysis

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Volume 65, Issue 5, Pages (May 2004)

Volume 55, Issue 2, Pages (February 1999)

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Advantage of Insulin Glulisine Over Regular Insulin in Patients With Type 2 Diabetes and Severe Renal Insufficiency Hiromi Urata, MD, Katsuhito Mori,

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 63, Issue 3, Pages (March 2003)

Volume 66, Issue 3, Pages (September 2004)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients Yukinobu Kuwamura,

Comorbidity and confounding in end-stage renal disease

Volume 64, Issue 1, Pages (July 2003)

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Volume 68, Issue 1, Pages (July 2005)

Volume 67, Issue 6, Pages (June 2005)

LDL cholesterol in CKD—to treat or not to treat?

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 67, Pages S48-S51 (January 2005)

Volume 75, Issue 1, Pages (January 2009)

Immunologic function and survival in hemodialysis patients

FGF-23 in patients with end-stage renal disease on hemodialysis

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

Volume 69, Issue 12, Pages (June 2006)

Volume 61, Issue 2, Pages (February 2002)

Elevated risk of stroke among patients with end-stage renal disease

Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease Yoshiki Nishizawa,

Volume 87, Issue 1, Pages (January 2015)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Volume 68, Issue 2, Pages (August 2005)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 74, Issue 5, Pages (September 2008)

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 67, Issue 5, Pages (May 2005)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,

Prehypertension: is it relevant for nephrologists?

Homocysteine, renal function, and risk of cardiovascular disease

Volume 63, Issue 2, Pages (February 2003)

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Treatment of the primary hyperoxalurias: A new chapter

Volume 83, Issue 3, Pages (March 2013)

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 70, Issue 5, Pages (September 2006)

Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1 William M.

Volume 75, Issue 7, Pages (April 2009)

Volume 72, Issue 11, Pages (December 2007)

Volume 64, Issue 3, Pages (September 2003)

Volume 70, Issue 10, Pages (November 2006)

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Volume 61, Issue 6, Pages (June 2002)

Prediction in idiopathic membranous nephropathy

Volume 67, Issue 4, Pages (April 2005)

Volume 57, Pages S44-S48 (April 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 62, Issue 6, Pages 2230-2237 (December 2002) Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease Tetsuo Shoji, Mariko Fukumoto, Eiji Kimoto, Kayo Shinohara, Masanori Emoto, Hideki Tahara, Hidenori Koyama, Eiji Ishimura, Tatsuya Nakatani, Takami Miki, Yoshihiro Tsujimoto, Tsutomu Tabata, Yoshiki Nishizawa Kidney International Volume 62, Issue 6, Pages 2230-2237 (December 2002) DOI: 10.1046/j.1523-1755.2002.00692.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Serum anti-oxidized low-density lipoprotein (anti-oxLDL) antibody titer in the cohort of patients with end-stage renal disease (ESRD). Serum anti-oxLDL antibody at baseline showed a skewed distribution with a median of 320 mU/mL (range 103 to 1558 mU/mL; N = 249). Kidney International 2002 62, 2230-2237DOI: (10.1046/j.1523-1755.2002.00692.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Anti-oxLDL antibody at baseline and mortality. The cohort of 249 patients with ESRD was divided into two groups according to serum titer of anti-oxLDL antibody titer, and mortality rates were compared by the Kaplan-Meier method followed by log-rank test. Those with a higher titer showed a significantly lower risk of cardiovascular mortality. Kidney International 2002 62, 2230-2237DOI: (10.1046/j.1523-1755.2002.00692.x) Copyright © 2002 International Society of Nephrology Terms and Conditions